Supported by

Stable CAD (Coronary artery disease)

Find all the latest content on stable coronary artery disease (stable CAD) published on this website.

A complex and changing disease state requiring wide expertise, stable CAD can involve a diverse range of underlying chronic or evolutionary stages involving full use of all available tools, devices and techniques like those for invasive imaging and functional assessment. Taking into account underlying comorbidities such as diabetes is critical. Advances in imaging techniques, as well as the use of adjunctive pharmacotherapy, vascular access or invasive interventions such as bypass surgery, are important, as are understanding bleeding risks, all of which can be found here…

Filtered By
Stable CAD

276 results

Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study

25 Aug 2022

In this post-hoc analysis of the TWILIGHT trial, the authors report the effects of ticagrelor monotherapy compared to ticagrelor and aspirin in patients with prior CABG at least three months post PCI with no adverse events and at least one clinical and one angiographic high-risk feature...

Nicola Ryan

Reviewer

Nicola Ryan
Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study

FFR-guided PCI optimization directed by high-definition IVUS versus standard of care - the FFR-REACT trial

24 Aug 2022

The primary objective of the study was to assess whether an IVUS-based stent optimization provided an incremental value in terms of vessel-related adverse event occurrence in patients presenting with low post-PCI FFR (<0.90).

Simone Fezzi

Reviewer

Simone Fezzi
M. Pighi

Reviewer

Michele Pighi
FFR-guided PCI optimization directed by high-definition IVUS versus standard of care - the FFR-REACT trial

How can physiology guide you in non LM bifurcation PCI?

18 Dec 2019

View the replay of this webinar on physiology with Jens Flensted Lassen, Lisette Okkels Jensen, Thomas Engstroem and Anders Junker

How can physiology guide you in non LM bifurcation PCI?

How physiology can guide you in LM PCI?

05 Nov 2019

View this replay of a LIVE Webinar - How physiology can guide you in LM PCI? With Jose M De La Torre Hernandez, Flavio Ribichini and Dae-Hyun Lee Hwang

How physiology can guide you in LM PCI?

How the QFR in your cathlab can help us to assess non-invasively the coronary physiology?

27 Oct 2021

Discover the replay of this PCR Webinar on coronary physiology with M. Gilard, H. D. Mejía-Rentería and D. Leistner

How the QFR in your cathlab can help us to assess non-invasively the coronary physiology?

Closing the loop of coronary physiology: from FFR to microvascular resistance reserve (​MRR)

14 Dec 2021

Watch the replay of this PCR Webinar on coronary physiology with J. Escaned , C. Berry, B. De Bruyne and N. HJ Pijls

Closing the loop of coronary physiology: from FFR to MRR

PPG: a novel dimension in coronary physiology

24 Nov 2021

Discover the replay of this PCR Webinar on coronary physiology with B. De Bruyne, C. Collet, D. Perera and J. Sonck

PPG: a novel dimension in coronary physiology

Should we measure FFR post-PCI?

26 Oct 2021

Discover the replay of this PCR Webinar on coronary physiology with B. De Bruyne, C. Collet, D. Collison and J. Escaned

Should we measure FFR post-PCI?

How to use invasive coronary physiology in ACS patients?

23 Sep 2021

Watch the replay of this webinar on coronary physiology with F. Alfonso, T. Engstrom, T. Keeble and R. Kharbanda

How to use invasive coronary physiology in ACS patients?

How to use Invasive Coronary Physiology to assess LM disease, pre-TAVI and pre-CABG interventions?

31 Aug 2021

Watch the replay of this webinar on coronary physiology with R. Al-Lamee, E. Barbato, B. De Bruyne and N. Gonzalo

How to use Invasive Coronary Physiology to assess LM disease, pre-TAVI and pre-CABG interventions?